NCT04317690|CompletedResults
Loading search results
Sponsor study identifier
observational
539
1 country
1
Study Start
March 17, 2020
Actual (reported)Primary Completion
June 29, 2020
Actual (reported)Study Completion
June 29, 2020
Actual (reported)The purpose of this study is to survey a sample of adults who have recently made a decision about treatment of high cholesterol or high blood pressure or a decision about screening for colorectal cancer, breast cancer, or prostate cancer. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions for these common medical situations.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 29, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 17, 2020
Actual (reported)March 19, 2020
Actual (reported)March 23, 2020
Actual (reported)June 29, 2020
Actual (reported)June 29, 2020
Actual (reported)May 20, 2022
Actual (reported)Shared Decision Making Process Measure
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
Baseline survey
Decisional Conflict Tool (SURE)
Baseline survey
Decision Regret Scale
Baseline survey
People between the ages of 30-75 ,with no previous heart attack or stroke history, who have been diagnosed with high cholesterol, who are either taking medication for high cholesterol for 2 years or less; or have discussed managing high cholesterol in the past 2 years. These people will see items only pertaining to high cholesterol.
People between the ages of 30-75 ,with no previous heart attack or stroke history, who have been diagnosed with high blood pressure, who are either taking medication for high blood pressure for 2 years or less; or have discussed managing high blood pressure in the past 2 years. These people will see items only pertaining to high blood pressure.
People between the ages of 50-75 with no previous diagnosis of colon cancer, who have been screened for colon cancer (or discussed screening for colon cancer) in the past 2 years, or who had first colon cancer screening in past 2 years. These people will see items only pertaining to colon cancer screening.
Females between the ages of 40-50 with no previous diagnosis of breast cancer who have had mammogram (or discussed having a mammogram) in the past 2 years, or had first mammogram in past 2 years. These people will see items only pertaining to breast cancer screening.
Men between the ages of 45-69 with no previous diagnosis of prostate cancer who have been screened for prostate cancer (or discussed screening for prostate cancer) in the past 2 years or had first prostate cancer screening in the past 2 years. These people will see items only pertaining to prostate cancer screening.
Sample was an online non-probability panel of adults living in the United States. Marketing Systems Group, the sample vendor, invited potential respondents from a targeted panel consisting of participants matching the sex, age, and group dynamics described above. In the survey, they were screened to meet our specific qualifications noted above.
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Karen Sepucha, PhD
Massachusetts General Hospital
539 participants (actual enrollment reported by the registry).
First Submitted
March 19, 2020
First Posted
March 23, 2020
Study Start
March 17, 2020
Actual (reported)KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice
Single-Item Measure of Decision Regret
Baseline survey
Treatment Choice
Baseline survey
Adapted Controlled Preference Scale
Baseline survey
Adherence
Baseline survey
Contact the study team to confirm eligibility.
Primary Completion
June 29, 2020
Actual (reported)Study Completion
June 29, 2020
Actual (reported)Last Updated
May 20, 2022
Results First Posted
May 20, 2022
Record last verified: 2022-05
The study team will create a complete, cleaned, de-identified copy of the final data set for each online field test.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: